本页面由Tiger Trade Technology Pte. Ltd.提供服务

奥麦罗制药

19.83
+0.71003.71%
盘后:19.950.1158+0.58%16:19 EDT
成交量:79.36万
成交额:1,563.83万
市值:14.35亿
市盈率:12.62
高:19.91
开:19.20
低:19.19
收:19.12
52周最高:21.24
52周最低:4.06
股本:7,237.54万
流通股本:6,825.80万
量比:0.87
换手率:1.16%
股息:- -
股息率:- -
每股收益(TTM):1.57
每股收益(LYR):-0.0527
净资产收益率:-576.33%
总资产收益率:-18.68%
市净率:-27.95
市盈率(LYR):-375.95

数据加载中...

2026/09/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/14

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/08/14

重要事件披露

Form 8-K - Current report
2026/08/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/13

重要事件披露

Form 8-K - Current report
2026/07/30

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/20

重要事件披露

Form 8-K - Current report
2026/07/06

重要事件披露

Form 8-K - Current report
2026/06/25

重要事件披露

Form 8-K - Current report
2026/06/18

重要事件披露

Form 8-K - Current report
2026/05/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]